These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29714547)

  • 1. A Comparative Safety Profile Assessment of Oncolytic Virus Therapy Based on Clinical Trials.
    Matsuda T; Karube H; Aruga A
    Ther Innov Regul Sci; 2018 Jul; 52(4):430-437. PubMed ID: 29714547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
    Zhang Y; Liu Z
    Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Application of Oncolytic Viruses: A Systematic Review.
    Cook M; Chauhan A
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory aspects of oncolytic virus products.
    Yamaguchi T; Uchida E
    Curr Cancer Drug Targets; 2007 Mar; 7(2):203-8. PubMed ID: 17346112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Virus-Driven Biotherapies from Bench to Bedside.
    Duan S; Wang S; Qiao L; Yu X; Wang N; Chen L; Zhang X; Zhao X; Liu H; Wang T; Wu Y; Li N; Liu F
    Small; 2023 Jun; 19(23):e2206948. PubMed ID: 36879416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiating oncolytic viruses by targeted drug intervention.
    Mahoney DJ; Stojdl DF
    Curr Opin Mol Ther; 2010 Aug; 12(4):394-402. PubMed ID: 20677090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies.
    Yamaguchi T; Uchida E
    Curr Cancer Drug Targets; 2018; 18(2):202-208. PubMed ID: 28228083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.
    Wei D; Xu J; Liu XY; Chen ZN; Bian H
    Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Considerations for Oncolytic Viral Therapies: A Regulatory Perspective.
    Liu K
    Clin Pharmacol Ther; 2017 May; 101(5):580-582. PubMed ID: 28130800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer.
    Kasuya H; Kodera Y; Nakao A; Yamamura K; Gewen T; Zhiwen W; Hotta Y; Yamada S; Fujii T; Fukuda S; Tsurumaru N; Kuwahara T; Kikumori T; Koide Y; Fujimoto Y; Nakashima T; Hirooka Y; Shiku H; Tanaka M; Takesako K; Kondo T; Aleksic B; Kawashima H; Goto H; Nishiyama Y
    Hepatogastroenterology; 2014 May; 61(131):599-605. PubMed ID: 26176043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of clinical trials assessing oncolytic virus therapy for urological cancers.
    Taguchi S; Fukuhara H; Homma Y; Todo T
    Int J Urol; 2017 May; 24(5):342-351. PubMed ID: 28326624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Trials with Oncolytic Viruses: Current and Future Prospects.
    Patil S; Rao RS; Majumdar B
    J Contemp Dent Pract; 2015 Aug; 16(8):i-ii. PubMed ID: 26423510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives.
    Taguchi S; Fukuhara H; Todo T
    Jpn J Clin Oncol; 2019 Mar; 49(3):201-209. PubMed ID: 30462296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization.
    Laurie SA; Bell JC; Atkins HL; Roach J; Bamat MK; O'Neil JD; Roberts MS; Groene WS; Lorence RM
    Clin Cancer Res; 2006 Apr; 12(8):2555-62. PubMed ID: 16638865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles to the Rescue: A Review of Oncolytic Measles Virus.
    Aref S; Bailey K; Fielding A
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic viruses: a new class of immunotherapy drugs.
    Kaufman HL; Kohlhapp FJ; Zloza A
    Nat Rev Drug Discov; 2015 Sep; 14(9):642-62. PubMed ID: 26323545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Assessment of the Health Risk for Livestock When Animal Viruses Are Applied in Human Oncolytic Therapy: A Case Study for Seneca Valley Virus.
    Schijven J; Brizee S; Teunis P; de Vos C; Eblé P; Rutjes S
    Risk Anal; 2019 May; 39(5):982-991. PubMed ID: 30395685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JX-594, a targeted oncolytic poxvirus for the treatment of cancer.
    Merrick AE; Ilett EJ; Melcher AA
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1372-82. PubMed ID: 19943208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.